Article
A metabolome-wide Mendelian randomization study prioritizes potential causal circulating metabolites for multiple sclerosis.
Journal of neuroimmunology - 15 Jun 2023
Ge Angela, Sun Yitang, Kiker Thaddaeus, Zhou Yanjiao, Ye Kaixiong
Abstract excerpt
To prioritize circulating metabolites that likely play causal roles in the pathogenesis of multiple sclerosis (MS). Two-sample Mendelian randomization analysis was performed to estimate the causal effects of 571 circulating metabolites on the risk of MS. Genetic instruments for circulating metabolites were obtained from three previous genome-wide association studies (GWAS) of the blood metabolome (N = 7824;...
Topics
Join the communities discussing this publication.
